iTeos Therapeutics, Inc. (ITOS)

NASDAQ: ITOS · IEX Real-Time Price · USD
25.36
+1.66 (7.00%)
At close: Aug 12, 2022 4:00 PM
25.44
+0.08 (0.32%)
After-hours: Aug 12, 2022 7:56 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Revenue
344.78000
Gross Profit
344.78000
Selling, General & Admin
40.5115.348.844.31
Research & Development
59.3729.919.2117.19
Operating Expenses
99.8745.2428.0521.5
Operating Income
244.9-45.24-28.05-21.5
Interest Expense / Income
0000.07
Other Expense / Income
-11.56-7.15-5.71-3.52
Pretax Income
256.46-38.09-22.34-18.05
Income Tax
41.94-0.060.120.01
Net Income
214.52-38.03-22.45-18.06
Preferred Dividends
05.374.082.01
Net Income Common
214.52-43.4-26.54-20.07
Shares Outstanding (Basic)
351501
Shares Outstanding (Diluted)
381501
Shares Change
150.49%7336.28%-67.03%-
EPS (Basic)
6.10-2.88-130.85-32.63
EPS (Diluted)
5.68-2.88-130.85-32.63
Free Cash Flow Per Share
14.55-1.69-117.69-31.42
Gross Margin
100.00%---
Operating Margin
71.00%---
Profit Margin
62.20%---
Free Cash Flow Margin
148.50%---
Effective Tax Rate
16.35%0.15%-0.53%-0.06%
EBITDA
257.07-37.56-21.72-17.48
EBITDA Margin
74.60%---
Depreciation & Amortization
0.60.540.610.51
EBIT
256.46-38.09-22.34-17.98
EBIT Margin
74.40%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).